Shannon Lee Layland
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shannon Lee Layland has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Katja Schenke-Layland
NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany
6 shared publications - Julia Marzi
Eberhard Karls University Tübingen
3 shared publications Abiramy Jeyagaran
Institute of Biomedical Engineering Department for Medical Technologies and Regenerative Medicine Eberhard Karls University Tübingen 72076 Tübingen Germany
2 shared publicationsAli Nsair
Division of Cardiology, Department of Medicine, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, California, United States
2 shared publicationsChuan-En Lu
Institute of Biomedical Engineering, Department for Medical Technologies and Regenerative Medicine, Silcherstr. 7/1, Eberhard Karls University, 72076 Tübingen, Germany
2 shared publicationsIvonne A. Montes-Mojarro
Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany
2 shared publications
Latest Publications
- Open Access
- 7 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (2) , e2403017
ECM Proteins Nidogen‐1 and Decorin Restore Functionality of Human Islets of Langerhans upon Hypoxic Conditions
Transplantation of donor islets of Langerhans is a potential therapeutic approach for patients with diabetes mellitus; however, its success is limited by islet death and dysfunction during the initial hypoxic conditions at the transplantation site. This highlights the need to support the donor islets in the days post‐transplantation until the site is vascularized. It was previously demonstrated that the extracellular matrix (ECM) proteins nidogen‐1 (NID1) and decorin (DCN) improve the functionality and survival of the β‐cell line, EndoC‐βH3, and the viability of human islets post‐isolation. To advance the use of these ECM proteins toward a clinical application and elucidate the mechanisms of action in primary islets, the study assesses the effects of ECM proteins NID1 and DCN on isolated human donor islets cultured in normoxic and hypoxic conditions. NID1‐ and DCN‐treatment restore β‐cell functionality of human donor islets in a hypoxic environment through upregulation of genes involved in glycolytic pathways and reducing DNA fragmentation in hypoxic conditions comparable to normoxic control islets. The results demonstrate that the utilization of NID1 or DCN with islets of Langerhans may have the potential to overcome the hypoxia‐induced cell death observed post‐transplantation and improve transplant outcomes.
- 7 November 2024
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (2) , e2403017
Open AccessECM Proteins Nidogen‐1 and Decorin Restore Functionality of Human Islets of Langerhans upon Hypoxic Conditions
Transplantation of donor islets of Langerhans is a potential therapeutic approach for patients with diabetes mellitus; however, its success is limited by islet death and dysfunction during the initial hypoxic conditions at the transplantation site. This highlights the need to support the donor islets in the days post‐transplantation until the site is vascularized. It was previously demonstrated that the extracellular matrix (ECM) proteins nidogen‐1 (NID1) and decorin (DCN) improve the functionality and survival of the β‐cell line, EndoC‐βH3, and the viability of human islets post‐isolation. To advance the use of these ECM proteins toward a clinical application and elucidate the mechanisms of action in primary islets, the study assesses the effects of ECM proteins NID1 and DCN on isolated human donor islets cultured in normoxic and hypoxic conditions. NID1‐ and DCN‐treatment restore β‐cell functionality of human donor islets in a hypoxic environment through upregulation of genes involved in glycolytic pathways and reducing DNA fragmentation in hypoxic conditions comparable to normoxic control islets. The results demonstrate that the utilization of NID1 or DCN with islets of Langerhans may have the potential to overcome the hypoxia‐induced cell death observed post‐transplantation and improve transplant outcomes.
- Open Access
- 1 July 2023
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 325 (1) , C332-C343
Exploring the relationship between epigenetic DNA methylation and cardiac fibrosis through Raman microspectroscopy
Cardiomyopathies are associated with severe fibrotic remodeling of the heart, which is characterized by the excessive accumulation of collagen type I (COL I). In this study, we used marker-independent Raman microspectroscopy (RMS) to gain a deeper understanding of the disease’s underlying molecular and cellular mechanisms.
- 1 July 2023
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 325 (1) , C332-C343
Open AccessExploring the relationship between epigenetic DNA methylation and cardiac fibrosis through Raman microspectroscopy
Cardiomyopathies are associated with severe fibrotic remodeling of the heart, which is characterized by the excessive accumulation of collagen type I (COL I). In this study, we used marker-independent Raman microspectroscopy (RMS) to gain a deeper understanding of the disease’s underlying molecular and cellular mechanisms.
- Open Access
- 16 March 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 162, 278-291
Raman microspectroscopy identifies fibrotic tissues in collagen-related disorders via deconvoluted collagen type I spectra
- 16 March 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 162, 278-291
Open AccessRaman microspectroscopy identifies fibrotic tissues in collagen-related disorders via deconvoluted collagen type I spectra
- Open Access
- 21 August 2022
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 189, 114481
Type 1 diabetes and engineering enhanced islet transplantation
- 21 August 2022
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 189, 114481
Open AccessType 1 diabetes and engineering enhanced islet transplantation
- Open Access
- 1 January 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 137, 92-102
Basement membrane proteins improve human islet survival in hypoxia: Implications for islet inflammation
- 1 January 2022
- Published by Elsevier in Acta Biomaterialia
- Vol. 137, 92-102
Open AccessBasement membrane proteins improve human islet survival in hypoxia: Implications for islet inflammation
- 29 May 2020
- Published by Elsevier
- p. 401-413
Use of Extracellular Matrix Proteins and Natural Materials in Bioengineering
- 29 May 2020
- Published by Elsevier
- p. 401-413
Use of Extracellular Matrix Proteins and Natural Materials in Bioengineering